Outcomes of antiretroviral therapy in a northern Indian urban clinic

Bulletin of the World Health Organization

Volumn 88, Issue 3, 2010, Pages 222-226

  Sharma, Surendra K ^a   Dhooria, Sahajal ^a   Prasad, K T ^a   George, Ninoo ^a   Ranjan, Sanjay ^a   Gupta, Deepak ^a   Sreenivas, Vishnubhatla ^a   Kadhiravan, Tamilarasu ^b   Miglani, Sunita ^a   Sinha, Sanjeev ^a   Wig, Naveet ^a   Biswas, Ashutosh ^a   Vajpayee, Madhu ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EFAVIRENZ; LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE;

ANTIMICROBIAL ACTIVITY; BLOOD; BODY MASS; DISEASE TREATMENT; GUIDELINE; HUMAN RESOURCE; NATIONAL STRATEGY; SOCIOECONOMIC STATUS; URBAN AREA;

ADOLESCENT; ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CD4 LYMPHOCYTE COUNT; CLINICAL TRIAL; FEMALE; FOLLOW UP; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HEALTH CENTER; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRACTICE GUIDELINE; SOCIAL STATUS; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; URBAN AREA;

ADOLESCENT; ADULT; ANTI-RETROVIRAL AGENTS; FEMALE; HIV INFECTIONS; HUMANS; INDIA; MALE; MIDDLE AGED; OBSERVATION; OUTCOME ASSESSMENT (HEALTH CARE); PROSPECTIVE STUDIES; URBAN HEALTH SERVICES; YOUNG ADULT;

INDIA;

EID: 77649148267     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.09.068759     Document Type: Article

References (14)

1. AIDS epidemic update: 2007. Geneva: Joint United Nations Programme on HIV/AIDS and World Health Organization; 2007. Available from: http://data. unaids.org/pub/EPISlides/2007/2007-epiupdate-en.pdf [accessed 30 May 2009].
2. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338:853-60. doi:10.1056/NEJM199803263381301 PMID:9516219
3. Mocroft A, Vella S, Benoeld TL, Chiesi A, Miller V, Gargalianos P, et al. Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet 1998;352:1725-30. doi:10.1016/S0140-6736(98) 03201-2 PMID:9848347
4. Severe P, Leger P, Charles M, Noel F, Bonhomme G, Bois G, et al. Antiretroviral therapy in a thousand patients with AIDS in Haiti. N Engl J Med 2005;353:2325-34. doi:10.1056/NEJMoa051908 PMID:16319381
5. Stringer JS, Zulu I, Levy J, Stringer EM, Mwango A, Chi BH, et al. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA 2006;296:782-93. doi:10.1001/jama.296.7.782 PMID:16905784
6. National AIDS Control Organisation, Ministry of Health and Family Welfare, Government of India. Operational guidelines for ART centres. New Delhi: National AIDS Control Organisation, Ministry of Health and Family Welfare, Government of India; 2008. Available from: http://www.nacoonline.org/ upload/Care&Treatment/ART operational guidelines 2008.pdf [accessed 30 May 2009].
7. Antiretroviral therapy guidelines for HIV-infected adults and adolescents including post-exposure prophylaxis. New Delhi: National AIDS Control Organization, Ministry of Health and Family Welfare, Government of India; 2007. Available from: http://upaidscontrol.up.nic.in/Guidelines/ Antiretroviral Therapy Guidelines for HIV infected Adults an.pdf.[accessed 30 May 2009].
8. Chauhan LS, Agarwal SP. Revised national tuberculosis control programme: TBC India. Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India. Available from: http://www.tbcindia.org/pdfs/Tuberculosis Control in India.pdf [accessed 21 October 2009].
9. National AIDS Control Organisation [Internet site]. Available from: http://www. nacoonline.org/Quick-Links/HIV-Data/ [accessed 20 October 2009].
10. Stringer JS, Zulu I, Levy J, Stringer EM, Mwango A, Chi BH, et al. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA 2006;296:782-93. doi:10.1001/jama.296.7.782 PMID:16905784
11. The ART-LINC Collaboration and ART-CC Groups. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between lowincome and high income countries. Lancet 2006;367:817-24. doi:10.1016/S0140-6736(06)68337-2 PMID:16530575
12. Whalen CC, Nsubuga P, Okwera A, Johnson JL, Hom DL, Michael NL, et al. Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda. AIDS 2000;14:1219-28. doi:10.1097/00002030-200006160-00020 PMID:10894287
13. Brinkhof MW, Pujades-Rodriguez M, Egger M. Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS ONE 2009;4:e5790. doi:10.1371/journal.pone.0005790 PMID:19495419
14. Sarna A, Pujari S, Sengar AK, Garg R, Gupta I, Dam J. Adherence to antiretroviral therapy and its determinants amongst HIV patients in India. Indian J Med Res 2008;127:28-36. PMID:18316850